MYC and T-cell acute lymphoblastic leukemia: Using EU-MYC model of T-cell acute lymphoblastic leukemia, we reported that SCA1+ CSCs use MYC–HIF-2α stemness pathway to suppress p53 and decrease ROS production (1).